Indaptus Therapeutics Files Prospectus Related To The Proposed Resale Of Up To 58,895,000 Shares Of Common Stock By Selling Stockholders
https://www.sec.gov/Archives/edgar/data/1857044/000149315226038780/forms-3.htm
Read original at benzingaFilings · News reference
Reference details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
https://www.sec.gov/Archives/edgar/data/1857044/000149315226038780/forms-3.htm
Read original at benzingaFiled: 2026-08-13 AccNo: 0001493152-26-037574 Size: 304 KB Item 2.02: Results of Operations and Financial Condition Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and Exhibits
Read original at edgarIndaptus Therapeutics (NASDAQ:INDP) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(1.57) by 98.73 percent. This is a 99.78 percent increase over losses of $(9.09) per share
Read original at benzinga